Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
Authors
Keywords
-
Journal
Lancet Microbe
Volume 3, Issue 12, Pages e944-e955
Publisher
Elsevier BV
Online
2022-11-12
DOI
10.1016/s2666-5247(22)00287-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
- (2022) Stefan Pilz et al. ENVIRONMENTAL RESEARCH
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
- (2022) Daniel R Feikin et al. LANCET
- Waning effectiveness of COVID-19 vaccines
- (2022) Hiam Chemaitelly et al. LANCET
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
- (2022) Hiam Chemaitelly et al. Nature Communications
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
- (2022) Hiam Chemaitelly et al. Nature Communications
- SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
- (2022) Kaori Sano et al. Nature Communications
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19
- (2021) Houssein H Ayoub et al. Journal of Global Health
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
- (2021) Laith J. Abu-Raddad et al. Scientific Reports
- SARS-CoV-2 infection is at herd immunity in the majority segment of the population of Qatar
- (2021) Mohamed H Al-Thani et al. Open Forum Infectious Diseases
- Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
- (2021) Mohammad R. Hasan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses
- (2021) Laith J Abu-Raddad et al. JOURNAL OF TRAVEL MEDICINE
- mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
- (2021) Hiam Chemaitelly et al. NATURE MEDICINE
- SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
- (2021) Shaheen Seedat et al. Scientific Reports
- SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
- (2021) Peter V. Coyle et al. iScience
- A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
- (2021) N. Kojima et al. EVALUATION & THE HEALTH PROFESSIONS
- Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
- (2021) Laith J. Abu-Raddad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
- (2021) Noam Barda et al. LANCET
- BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
- (2021) Patrick Tang et al. NATURE MEDICINE
- Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
- (2021) Laith J. Abu-Raddad et al. PLOS MEDICINE
- One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
- (2021) Fatiha M. Benslimane et al. Frontiers in Cellular and Infection Microbiology
- Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
- (2021) Lorenzo Azzi et al. EBioMedicine
- Temporal dynamics in viral shedding and transmissibility of COVID-19
- (2020) Xi He et al. NATURE MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.
- (2016) Miguel A. Hernán et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research
- (2009) Peter C. Austin COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now